Rethinking neurodegenerative disease treatment: Target multiple pathological proteins, not just one

July 5, 2018, Perelman School of Medicine at the University of Pennsylvania
Credit: CC0 Public Domain

Nearly all major neurodegenerative diseases—from Alzheimer's to Parkinson's—are defined and diagnosed by the presence of one of four proteins that have gone rogue: tau, amyloid-beta (Aβ), alpha-synuclein (α-syn), or TDP-43. As such, investigational drugs and studies aimed at preventing or slowing the disease often hone in on just one of these respective proteins. However, targeting multiple proteins—known as "proteinopathies"—at once may be the real key, according to a recent study published in Brain by Penn Medicine researchers.

These so-called "proteinopathies"—misfolded proteins that accumulate and destroy neurons—co-exist in varying degrees across all of the different neurodegenerative disorders and may instigate each other to drive disease severity in many aging patients. The prevalence of these co-pathologies suggests that each disease may ultimately require combination therapy targeting multiple disease proteins, and not just a single therapy, in patients with both early and later-stage disease.

"Historically, the focus of most clinical trials has been on targeting the primary pathological proteins of a given neurodegenerative disease such as deposits of tau and Aβ for Alzheimer's disease, but we see now that many of these disease-related aggregated proteins affect most older patients across a full spectrum of clinical and neuropathological presentations," said senior author John Q. Trojanowski, MD, Ph.D., a professor of Pathology and Laboratory Medicine and director of Penn's Institute on Aging. "This gives us additional leverage to find ways to detect patients' specific proteinopathies with increasingly sophisticated biomarker and imaging technologies. This will allow us, and other researchers, to better match participants with specific targeted therapies in clinical trials."

The study—which analyzed 766 autopsied brains at Penn's Center for Neurodegenerative Disease Research (CNDR)—revealed that patients with more severe forms of their diseases had more co-pathologies. Researchers also found that increased age and the presence of the APOE ε4 allele—a typical gene variant associated with an increased risk for late-onset Alzheimer's disease—are risk factors for co-pathologies.

The researchers studied patients with the following diseases: Alzheimer's disease, Pick's disease, corticobasal degeneration (CBD), progressive supranuclear palsy, multiple system atrophy, Parkinson's disease with and without dementia, dementia with Lewy bodies, as well as frontotemporal lobar degeneration with TDP-43, amyotrophic lateral sclerosis, and primary age-related tauopathy (PART).

While co-pathologies have been observed in Alzheimer's and Lewy body disease, tau, Aβ, α-syn, and TDP-43 co-pathologies are rarely reported in the other .

The CNDR researchers found that co-pathologies were common but varied among the disease groups, ranging from 27 to 81 percent of patients having co-pathologies. For example, 52 percent of patients with CBD, in which tau as the primary protein, had multiple other neurodegenerative disease protein deposits present.

Tau was nearly universal, with 92 to 100 percent of all patients having at least one form. Aβ was next, with 20 to 57 percent of patients having at least one type of protein deposit, while α-syn pathology, typically seen in Parkinson's disease, was less common, with 4 to 16 percent. TDP-43 deposits, which are characteristic pathological signatures of and , were the rarest, with 0 to 16 percent of patients having these deposits.

In several neurodegenerative diseases, co-pathologies increased more considerably. For example, in patients with Alzheimer's disease (tau and Aβ deposits are the primary signatures), α-syn pathology—similar to that of a Lewy body—increased by up to 55 percent and TDP-43 by up to 40 percent.

The findings not only show a high prevalence of co-pathologies, but also suggest a patient's primary pathological protein may influence co-pathology prevalence and severity, as shown in patients with Alzheimer's and Lewy body disease patients.

The presence of multiple co-pathologies increased from 9 percent to 25 percent between intermediate Alzheimer's and higher-level Alzheimer's patients, and from 0 percent to 21 percent between brainstem- or amygdala-only Lewy body disease and the more aggressive neocortical Lewy body disease.

These findings support the "proteopathic seeding" hypothesis that has been previously established in model systems of neurodegenerative diseases. Misfolded proteins may directly "cross-seed" other normal, vulnerable proteins to accumulate and clump via a cell-to-cell transfer of toxic proteins.

"Our study is an important first step in understanding the extent to which co-pathologies present in and impact all neurodegenerative diseases," said co-author Virginia M.-Y. Lee, Ph.D., the CNDR director and a professor of Pathology and Laboratory Medicine. "Now we need to probe these protein-to- interactions more closely to better understand how they progress in ' brains, with an eye toward clinical studies that combine targeted therapies to halt or slow accumulation of these proteins."

Explore further: Diverse Parkinson's-related disorders may stem from different strains of same protein

Related Stories

Diverse Parkinson's-related disorders may stem from different strains of same protein

May 9, 2018
Different Parkinson's-related brain disorders, called synucleionpathies, are characterized by misfolded proteins embedded in cells. Researchers in the Perelman School of Medicine at the University of Pennsylvania found that ...

Scientists show that a key Parkinson's biomarker can be identified in the retina

June 8, 2018
A study involving scientists from the University of Alicante and the United States notes that the accumulation of a protein known as alpha-synuclein in the retina is a key Parkinson's biomarker that could help detect the ...

Abnormal brain protein may contribute to Alzheimer's disease development

September 30, 2016
A recently-recognized pathologic protein in the brain may play a larger role in the development of clinical Alzheimer's disease dementia than previously recognized, according to a study by researchers at Rush University Medical ...

Molecular link between Parkinson's disease and prion diseases

September 15, 2017
Parkinson's disease and prion diseases are very different as regards both origins and course. Nonetheless, a research group of SISSA, headed by Professor Giuseppe Legname, has discovered an unexpected and important link between ...

Alzheimer's may affect the brain differently in African-Americans than European-Americans

July 15, 2015
Alzheimer's disease may cause different changes in the brain, or pathologies, in African-Americans than in white Americans of European descent, according to a study published in the July 15, 2015, online issue of the medical ...

New Alzheimer's animal model more closely mimics human disease

December 4, 2017
By injecting human Alzheimer's disease brain extracts of pathological tau protein (from postmortem donated tissue) into mice with different amounts of amyloid-β (Aβ) plaques in their brains, researchers from the Perelman ...

Recommended for you

The neurobiology of fruit fly courtship helps illuminates human disorders of motivation

July 13, 2018
Two fruit flies meet in an acrylic mating chamber and check each other out. It's the insect version of speed dating for science.

Fragile X: New drug strategy corrects behavior/biochemical measures in mouse model

July 13, 2018
Research in mice shows that a pharmacological strategy can alleviate multiple behavioral and cellular deficiencies in a mouse model of fragile X syndrome (FXS), the most common inherited form of intellectual disability and ...

Chemicals associated with oxidative stress may be essential to development

July 12, 2018
Some level of molecules linked to oxidative stress may be essential to health and development, according to new animal studies.

The VIPs of the nervous system—a tiny population of neurons holds a master key to the body's clock

July 12, 2018
Travel by airplane has opened the door to experiencing different cultures and exploring natural wonders. That is, if you can get past the jet lag.

Novel therapy delays muscle atrophy in Lou Gehrig's disease model

July 12, 2018
Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig's disease, according to a new study out of Case Western Reserve University School of Medicine. Researchers found high levels ...

Why are neuron axons long and spindly? Study shows they're optimizing signaling efficiency

July 11, 2018
A team of bioengineers at UC San Diego has answered a question that has long puzzled neuroscientists, and may hold a key to better understanding the complexities of neurological disorders: Why are axons, the spindly arms ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.